Article: Allergan names Amylin's Greene to board of directors. (Howard E. Green)

ALLERGAN NAMES AMYLIN'S GREENE TO BOARD OF DIRECTORS

IRVINE, Calif., Oct. 24 /PRNewswire/ -- Allergan Inc. (NYSE: AGN), one of the world's leading eye care companies, announced that Howard E. (Ted) Greene, Jr., Chairman and Chief Executive Officer of Amylin Corporation, has been appointed to its board of directors. Greene's appointment, effective immediately, will increase the number of Allergan directors to twelve.

Commenting on Greene's appointment, Gavin S. Herbert, Chairman and Chief Executive Officer of Allergan, said, "We are extremely pleased to have Ted join our board. His experience in health care and technology management will enhance ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!